GLP-1 Drugs Drive Major Canadian Employer Drug Plan Cost Increases Advertisement Felix GLP-1 medications are driving significant cost increases for Canadian employer drug plans in 2026, according to a new Benefits Canada report analyzing prescription drug spending trends
Anchored by Wellstar MCG Health Medical Centers Rural Healthcare Access Partnership, an initiative funded by a $1.2 million grant from the U.S
Neuron, 109 (3), 461472
By focusing on restoring butyrate-producing gut bacteria, women can achieve: Better digestion & reduced bloating More stable energy levels Improved insulin sensitivity & weight management Enhanced mental clarity & mood stability Reasons For a Low GLP-1 and Butyrate Level in Women Chronic stress Diets high in processed foods and refined sugars Dysbiosis (Lack of butyrate-producing bacteria, low diversity) Endocrine disorders Frequent antibiotic use Hormonal fluctuations (e.g., perimenopause, menopause, PCOS) Inflammation Low resistant starch (e.g., green bananas, oats, beans) Low soluble fiber (e.g., apple, carrot, psyllium) Prolonged elimination diets Restrictive Diets Sedentary Lifestyle Sleep deprivation Symptoms of a Low GLP-1 and Butyrate This is a women-centric list of symptoms that can occur if GLP-1 and butyrate is low in the gut

In a cross-sectional multicenter study conducted by JSG-NAFLD, the presence of diabetes is associated with advanced fibrosis in 1365 biopsy-proven NAFLD patients [104]